These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21307076)

  • 41. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial.
    Raz I; Elias D; Avron A; Tamir M; Metzger M; Cohen IR
    Lancet; 2001 Nov; 358(9295):1749-53. PubMed ID: 11734230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
    von Herrath M; Bain SC; Bode B; Clausen JO; Coppieters K; Gaysina L; Gumprecht J; Hansen TK; Mathieu C; Morales C; Mosenzon O; Segel S; Tsoukas G; Pieber TR;
    Lancet Diabetes Endocrinol; 2021 Apr; 9(4):212-224. PubMed ID: 33662334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination therapy with anti-CD6 and oral insulin immunization reverses recent onset diabetes in non obese diabetic mice but fails to induce lasting tolerance.
    Schneider DA; Sarikonda G; Montero E; von Herrath MG
    Clin Immunol; 2013 Dec; 149(3):440-1. PubMed ID: 24211845
    [No Abstract]   [Full Text] [Related]  

  • 44. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
    Keymeulen B; Vandemeulebroucke E; Ziegler AG; Mathieu C; Kaufman L; Hale G; Gorus F; Goldman M; Walter M; Candon S; Schandene L; Crenier L; De Block C; Seigneurin JM; De Pauw P; Pierard D; Weets I; Rebello P; Bird P; Berrie E; Frewin M; Waldmann H; Bach JF; Pipeleers D; Chatenoud L
    N Engl J Med; 2005 Jun; 352(25):2598-608. PubMed ID: 15972866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes.
    Brezar V; Carel JC; Boitard C; Mallone R
    Endocr Rev; 2011 Oct; 32(5):623-69. PubMed ID: 21700723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of insulin resistance on proinsulin secretion in pregnancy: hyperproinsulinemia is not a feature of gestational diabetes.
    Retnakaran R; Hanley AJ; Sermer M; Zinman B
    Diabetes Care; 2005 Nov; 28(11):2710-5. PubMed ID: 16249544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Virtual optimization of nasal insulin therapy predicts immunization frequency to be crucial for diabetes protection.
    Fousteri G; Chan JR; Zheng Y; Whiting C; Dave A; Bresson D; Croft M; von Herrath M
    Diabetes; 2010 Dec; 59(12):3148-58. PubMed ID: 20864513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Six months of diazoxide treatment at bedtime in newly diagnosed subjects with type 1 diabetes does not influence parameters of {beta}-cell function and autoimmunity but improves glycemic control.
    Radtke MA; Nermoen I; Kollind M; Skeie S; Sørheim JI; Svartberg J; Hals I; Moen T; Dørflinger GH; Grill V
    Diabetes Care; 2010 Mar; 33(3):589-94. PubMed ID: 20028939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perinatal tolerance to proinsulin is sufficient to prevent autoimmune diabetes.
    Jhala G; Chee J; Trivedi PM; Selck C; Gurzov EN; Graham KL; Thomas HE; Kay TW; Krishnamurthy B
    JCI Insight; 2016 Jul; 1(10):e86065. PubMed ID: 27699217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
    Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes.
    Walter M; Kaupper T; Adler K; Foersch J; Bonifacio E; Ziegler AG
    Diabetes Care; 2010 Jul; 33(7):1443-8. PubMed ID: 20357369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
    Maron R; Melican NS; Weiner HL
    J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A study of serum free C-peptide responses to oral glucose load in diabetic patients: with special reference to types of diabetes and methods of treatment.
    Hsieh SD; Akanuma Y; Takaku F
    Tohoku J Exp Med; 1984 Mar; 142(3):249-60. PubMed ID: 6374968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.
    Pontiroli AE; Pacchioni M; Piatti PM; Cassisa C; Camisasca R; Pozza G
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance.
    Hao W; Greenbaum CJ; Krischer JP; Cuthbertson D; Marks JB; Palmer JP
    Diabetes Care; 2015 May; 38(5):891-6. PubMed ID: 25720600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of Preceding Ethanol Intake on Glucose Response to Low-Dose Glucagon in Individuals With Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study.
    Ranjan A; Nørgaard K; Tetzschner R; Steineck IIK; Clausen TR; Holst JJ; Madsbad S; Schmidt S
    Diabetes Care; 2018 Apr; 41(4):797-806. PubMed ID: 29358493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preventive effects of andrographolide on the development of diabetes in autoimmune diabetic NOD mice by inducing immune tolerance.
    Zhang C; Gui L; Xu Y; Wu T; Liu D
    Int Immunopharmacol; 2013 Aug; 16(4):451-6. PubMed ID: 23707775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
    MacNamara CM; Barrow BA; Manley SE; Levy JC; Clark A; Turner RC
    Diabetes Res Clin Pract; 2000 Oct; 50(2):117-26. PubMed ID: 10960722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial.
    Vehik K; Cuthbertson D; Ruhlig H; Schatz DA; Peakman M; Krischer JP;
    Diabetes Care; 2011 Jul; 34(7):1585-90. PubMed ID: 21610124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.
    Skyler JS; Krischer JP; Wolfsdorf J; Cowie C; Palmer JP; Greenbaum C; Cuthbertson D; Rafkin-Mervis LE; Chase HP; Leschek E
    Diabetes Care; 2005 May; 28(5):1068-76. PubMed ID: 15855569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.